CVS
CVS HEALTH Corp
NYSE · Healthcare · Medical - Healthcare Plans · US
$88.84
−1.58%Year over year
Reported trailing growth
- Revenue
- +7.4%
- EBITDA
- -5.4%
- EBIT
- -7.4%
- EPS
- +6.4%
- Free cash flow
- +146.0%
- Operating cash flow
- +95.3%
Forward estimates
Based on analyst estimates
- Revenue
- +1.6%
- EBITDA
- +57.5%
- EPS
- +112.6%
Three-year CAGR
- Revenue
- +7.6%
- EBITDA
- -7.2%
- EBIT
- +9.3%
- Net income
- -25.7%
- EPS
- -24.8%
- Free cash flow
- -16.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026